The Readout Loud
The Readout Loud
STAT
320: Jim Wilson's next venture, a surprise startup shutdown, & Lilly's Zepbound strategy
37 minutes Posted Aug 29, 2024 at 8:09 pm.
0:00
37:34
Download MP3
Show notes

STAT biotech reporter Jonathan Wosen joins us to discuss gene therapy pioneer Jim Wilson's exit from his decades-long tenure at the University of Pennsylvania. We also discuss the latest news in the life sciences, including the surprising collapse of a gene editing company, Eli Lilly's pitch to consumers, and more.